Related Experiment Video

Updated: Aug 15, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 15, 2011

Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators

T O'Reilly1, O Zak

  • 1Ciba-Geigy Limited, Basel, Switzerland.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|May 1, 1992
PubMed

Insights

Muramyl peptide immunomodulators enhance antimicrobial drug effectiveness and may reduce toxicity. These compounds show promise for treating infections, especially in immunocompromised patients.

Area of Science:

  • Immunology
  • Pharmacology
  • Infectious Diseases

Background:

  • Muramyl peptides are immunomodulators that enhance resistance to infections.
  • They also potentiate the efficacy of antimicrobial agents.
  • Their use in combination therapy for various infections has been explored.

Purpose of the Study:

  • To evaluate the efficacy of muramyl peptide immunomodulators in combination with antimicrobial agents.
  • To determine the conditions for effective combined administration.
  • To assess the potential benefits for immunocompromised hosts and prophylaxis.

Main Methods:

  • Experimental models of bacterial, fungal, parasitic, and viral infections were used.
  • Muramyl peptides were administered prophylactically in combination with anti-infective agents.
  • Efficacy was assessed based on increased anti-infective effects and reduced toxicity.

Main Results:

  • Prophylactic administration of muramyl peptides enhanced antimicrobial efficacy.
  • This enhancement was observed when the immunomodulator provided independent resistance.
  • Adjunctive use potentially reduced antimicrobial dosages and toxic side effects.

Conclusions:

  • Muramyl peptide immunomodulators can potentiate antimicrobial therapy.
  • They may improve outcomes in immunocompromised individuals.
  • Potential applications include prophylaxis in high-risk populations.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 27, 2016

Production and Testing of Antimicrobial Peptides and Their Mimics10:35

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...